Dr. Michael P. Krease, D.O.
Gastroenterology (Gastroenterology Physician)
- Medicare participating
At a glance
- Medical school
- West Virginia School of Osteopathic Medicine (2013)
- Years since graduation
- 13
- In the NPI registry since
- 2013
- Medicare patients seen, 2024
- 531
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2013Medical school: West Virginia School of Osteopathic Medicine
- 2013Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
KY license 03955
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Norton Hospitals, Inc Louisville, KY
- Baptist Health Louisville Louisville, KY
Medical groups
- Gastroenterology Health PArtners PLLC (29 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 531
- Services billed
- 5,265
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 151 | 142 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 127 | 127 |
| Established patient office or other outpatient visit, 30-39 minutes | 118 | 103 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 103 | 68 |
| New patient office or other outpatient visit, 45-59 minutes | 93 | 93 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 74 | 73 |
| Biopsy of large bowel using a flexible endoscope | 68 | 68 |
| Dilation of esophagus | 50 | 46 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 30 | 30 |
| Established patient office or other outpatient visit, 20-29 minutes | 25 | 23 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Omeprazole Other prescribers in Louisville, KY | 253 |
| Gavilyte-G (peg3350/sod sulf,bicarb,cl/kcl) Other prescribers in Louisville, KY | 185 |
| Pantoprazole Sodium Other prescribers in Louisville, KY | 152 |
| Dicyclomine Hcl Other prescribers in Louisville, KY | 120 |
| Gavilyte-C (peg3350/sod sulf,bicarb,cl/kcl) Other prescribers in Louisville, KY | 104 |
| Peg-3350 And Electrolytes (peg3350/sod sulf,bicarb,cl/kcl) Other prescribers in Louisville, KY | 50 |
| Ondansetron Odt (ondansetron) Other prescribers in Louisville, KY | 43 |
| Sod Sulf-Potass Sulf-Mag Sulf (sodium, potassium,mag sulfates) Other prescribers in Louisville, KY | 42 |
| Esomeprazole Magnesium Other prescribers in Louisville, KY | 38 |
| Famotidine Other prescribers in Louisville, KY | 37 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 21 companies reported 265 payments worth $161,369 in total to this clinician.
| Genzyme Corporation | $109,165 |
|---|---|
| Regeneron Healthcare Solutions, Inc. | $33,610 |
| Madrigal Pharmaceuticals | $13,773 |
| Phathom Pharmaceuticals, Inc. | $2,079 |
| AbbVie Inc. | $977 |
| Janssen Biotech, Inc. | $531 |
| Pfizer Inc. | $269 |
| Takeda Pharmaceuticals U.S.A., Inc. | $268 |
| Compensation for services other than consulting (speaking, faculty) | $145,255 |
|---|---|
| Consulting Fee | $7,200 |
| Food and Beverage | $4,527 |
| Travel and Lodging | $4,209 |
| Education | $177 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Genzyme Corporation Apr 10, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $8,725 |
| Genzyme Corporation Oct 16, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $8,725 |
| Genzyme Corporation Mar 3, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $7,329 |
| Regeneron Healthcare Solutions, Inc. Mar 8, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $7,329 |
| Genzyme Corporation Nov 19, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $7,329 |
| Regeneron Healthcare Solutions, Inc. Nov 7, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $7,329 |
| Genzyme Corporation Jul 19, 2025 | Consulting Fee | $7,200 |
| Genzyme Corporation Mar 12, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $5,933 |
| Genzyme Corporation Mar 13, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $5,933 |
| Genzyme Corporation Oct 23, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $5,933 |
All 63 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. Dec 16, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to PADUCAH, KY · in-kind | $224 |
| Genzyme Corporation Nov 19, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $7,329 |
| Genzyme Corporation Nov 19, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $3,839 |
| Genzyme Corporation Nov 19, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $3,389 |
| Genzyme Corporation Nov 19, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Nashville, TN | $132 |
| Genzyme Corporation Nov 19, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Nashville, TN | $127 |
| Genzyme Corporation Nov 19, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Columbia, TN | $63.84 |
| Regeneron Healthcare Solutions, Inc. Nov 14, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $1,745 |
| Regeneron Healthcare Solutions, Inc. Nov 7, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $7,329 |
| Regeneron Healthcare Solutions, Inc. Nov 7, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $4,537 |
| Janssen Biotech, Inc. Nov 7, 2025 | Education TREMFYA · Immunology · in-kind | $84.00 |
| Genzyme Corporation Oct 23, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $5,933 |
| Genzyme Corporation Oct 23, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $4,537 |
| Genzyme Corporation Oct 16, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $8,725 |
| Genzyme Corporation Oct 16, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Hickory, NC · in-kind | $841 |
| Genzyme Corporation Oct 16, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Hickory, NC | $69.11 |
| Genzyme Corporation Oct 16, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Hickory, NC | $20.00 |
| Madrigal Pharmaceuticals Sep 24, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $4,025 |
| Madrigal Pharmaceuticals Sep 24, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to LEXINGTON, KY | $95.20 |
| Genzyme Corporation Aug 19, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $3,839 |
| Madrigal Pharmaceuticals Aug 13, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $1,725 |
| Genzyme Corporation Jul 29, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $4,537 |
| Genzyme Corporation Jul 29, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $3,839 |
| Phathom Pharmaceuticals, Inc. Jul 23, 2025 | Compensation for services other than consulting (speaking, faculty) VOQUEZNA · Gastroenterology | $1,720 |
| Janssen Pharmaceuticals, Inc Jul 22, 2025 | Education in-kind | $9.24 |
| Genzyme Corporation Jul 19, 2025 | Consulting Fee | $7,200 |
| Genzyme Corporation Jul 19, 2025 | Travel and Lodging travel to Detroit, MI · in-kind | $552 |
| Genzyme Corporation Jul 19, 2025 | Travel and Lodging travel to Detroit, MI · in-kind | $259 |
| Madrigal Pharmaceuticals Jun 30, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,163 |
| Janssen Biotech, Inc. Jun 13, 2025 | Education TREMFYA · Immunology · in-kind | $84.00 |
| Madrigal Pharmaceuticals Jun 11, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,163 |
| Madrigal Pharmaceuticals Jun 11, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to LOUISVILLE, KY | $7.98 |
| Regeneron Healthcare Solutions, Inc. May 23, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to LOUISVILLE, KY · in-kind | $9.66 |
| Genzyme Corporation May 14, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $3,839 |
| Genzyme Corporation May 14, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $2,443 |
| Regeneron Healthcare Solutions, Inc. May 9, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $3,839 |
| Genzyme Corporation Apr 11, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $2,792 |
| Genzyme Corporation Apr 11, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Eatontown, NJ | $254 |
| Genzyme Corporation Apr 10, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $8,725 |
| Genzyme Corporation Apr 10, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Mt. Laurel Township, NJ · in-kind | $176 |
| Genzyme Corporation Apr 10, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Mt. Laurel Township, NJ | $175 |
| Genzyme Corporation Apr 10, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Mt. Laurel Township, NJ · in-kind | $165 |
| Genzyme Corporation Apr 10, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Mt. Laurel Township, NJ | $52.00 |
| Regeneron Healthcare Solutions, Inc. Mar 21, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $1,978 |
| Genzyme Corporation Mar 13, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $5,933 |
| Genzyme Corporation Mar 13, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $3,141 |
| Genzyme Corporation Mar 13, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $3,141 |
| Genzyme Corporation Mar 13, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Newburgh, IN | $90.58 |
| Genzyme Corporation Mar 13, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Newburgh, IN | $87.99 |
| Genzyme Corporation Mar 13, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Evansville, IN | $3.29 |
| Genzyme Corporation Mar 12, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $5,933 |
| Genzyme Corporation Mar 12, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Columbus, IN | $118 |
| Regeneron Healthcare Solutions, Inc. Mar 8, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $7,329 |
| Regeneron Healthcare Solutions, Inc. Mar 8, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to HERMITAGE, TN · in-kind | $266 |
| Genzyme Corporation Mar 3, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $7,329 |
| Genzyme Corporation Mar 3, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $4,537 |
| Genzyme Corporation Mar 3, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Somerset, KY | $119 |
| Genzyme Corporation Mar 3, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Corbin, KY | $109 |
| Regeneron Healthcare Solutions, Inc. Feb 20, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to OWENSBORO, KY · in-kind | $166 |
| Regeneron Healthcare Solutions, Inc. Feb 13, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $5,933 |
| Genzyme Corporation Jan 23, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $3,839 |
| Genzyme Corporation Jan 23, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to New Albany, IN | $26.74 |
| Madrigal Pharmaceuticals Jan 13, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $1,150 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 9 industry-funded studies in 2025, from 4 companies. The companies reported $283,578 in research payments for these studies, mostly to the institutions running them.
- A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab (REVAMP)
AbbVie Inc. - A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease (SIBERITE-1)
Genentech, Inc. - UC P3: Double-Blind Treat Straight Through
F. Hoffmann-la Roche AG - UC P3: Double-Blind Treat Straight Through
Genentech, Inc. - A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease (SIBERITE-1)
F. Hoffmann-la Roche AG - A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab
AbbVie Inc. · Active, not recruiting · NCT06880744 - A phase 3B, randomized, multicenter, controlled study of mirikizumab and placebo or mirikizumab concomitantly administered with tirzepatide in adult participants with moderately to severely active crohns disease and o…
Eli Lilly and Company - A phase 3B, randomized, multicenter, controlled study of mirikizumab and placebo or mirikizumab concomitantly administered with tirzepatide in adult participants with moderately to severely active ulcerative colitis a…
Eli Lilly and Company - LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Eli Lilly and Company · Recruiting · NCT07186101
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.